How do you approach the use of biologics in patients with a history of Guillain-Barre syndrome?

Onset of demyelinating neuropathies after TNF-inhibitor treatment has been reported in a small fraction of patients treated with these agents. Although their effects on patients with a history of GBS have not been systematically studied, TNF inhibitors are generally avoided in patients with history of demyelinating neuropathies, including GBS.